Targeted gene delivery using humanized single‐chain antibody with negatively charged oligopeptide tail
- 1 May 2004
- journal article
- Published by Wiley in Cancer Science
- Vol. 95 (5) , 424-429
Abstract
We have recently developed the so-called recombinant immunoporter as a non-viral vector based on a single-chain antibody (scFv) derived from a monoclonal antibody B4G7 against epidermal growth factor (EGF) receptor. This immunoporter (mBBD20) was composed of single-chain antibody and negatively charged oligopeptide tail [5 units of Asn4Ser (D20)], and was expressed in yeast as a secreted protein. The purified mBBD20 was converted to an immunogene by mixing it with DNA and a cationic polymer, polyethyleneimine (PEI). The resulting complex, namely recombinant immunogene, exhibited gene transfer activity with EGFR-specificity in vitro (Suzuki et al., Gene Ther. 2003). In this paper, we further improved various conditions necessary for the formation of the proper recombinant immunogene, retaining receptor specificity of its binding, intracellular processing of the receptor-bound gene, and efficient gene expression. Moreover, we provided evidence that the recombinant immunoporter made with humanized scFv could be used as a potent gene transfer vehicle to target particular tumor cells. This approach seems worthy of clinical trial.Keywords
This publication has 18 references indexed in Scilit:
- Recombinant single-chain antibodies with various oligopeptide tails for targeted gene deliveryGene Therapy, 2003
- Prodrug-activating systems in suicide gene therapyJournal of Clinical Investigation, 2000
- Very high expression of an anti-carcinoembryonic antigen single chain Fv antibody fragment in the yeast Pichia pastorisJournal of Biotechnology, 2000
- Ex vivoDelivery of Suicide Genes into Melanoma Cells Using Epidermal Growth Factor Receptor-specific Fab ImmunogeneJapanese Journal of Cancer Research, 1999
- Targeted In Vivo Delivery of Therapeutic Gene into Experimental Squamous Cell Carcinomas Using Anti-Epidermal Growth Factor Receptor Antibody: Immunogene ApproachHuman Gene Therapy, 1998
- A novel gene delivery system using EGF receptor‐mediated endocytosisFEBS Letters, 1994
- Detection of Epidermal Growth Factor Receptors and E‐Cadherins in the Basolateral Membrane of A431 Cells by Laser Scanning Fluorescence MicroscopyJapanese Journal of Cancer Research, 1991
- Subcellular localization of the EGF receptor maturation processExperimental Cell Research, 1989
- Biosynthesis of the epidermal growth factor receptor in human squamous cell carcinoma lines: Secretion of the truncated receptor is not common to epidermal growth factor receptor-hyperproducing cells.Cell Structure and Function, 1988
- Monoclonal antibody that immunoreacts with a subclass of human receptors for epidermal growth factor.Cell Structure and Function, 1985